Galapagos NV at Citi Biopharma Conference (Virtual) Transcript
So good afternoon, everyone. Sorry for the slight delay, technical difficulties. Bart, myself and the team were in separate rooms. But we're here now, day 2 of Citi's BioPharma Conference. It's Pete Verdult here. And on behalf of the team, I'm delighted to introduce Bart Filius, President and COO of Galapagos, along with the IR team. Bart's going to make some introductory remarks before we head into Q&A. As I always say, I'm here to moderate, not to monopolize. So you do have the function on screen to submit your questions. They will be e-mailed through to me or you can just e-mail me direct or make sure anything that comes through gets put to Bart and the team.
So without further ado, Bart, over to you.
Yes. Hi, Peter, and thanks for having me in the conference. Pleasure, as always, to speak with you and the rest of the audience. Indeed, I thought it would be good to just take you through a couple of slides, roughly 10
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
